Loading clinical trials...
Loading clinical trials...
The purpose of this qualitative study is to find out which technological translation tools can be used to improve Dutch-speaking care in all Brussels out-of-hours primary care services.
Previous studies have shown that language barriers in healthcare can lead to communication problems between healthcare provider and patient. This can lead to a decrease in satisfaction, quality of care and patient safety. Dutch speakers are a minority in Brussels (a Dutch-French bilingual region in Belgium), and the majority of general practitioners (GPs) in the Brussels out-of-hours primary care services are French-speaking. Measures are already being taken to increase the number of bilingual (Dutch and French) GPs. In addition, several technological tools (e.g. video interpreting, translation apps, ...) exist to overcome language barriers. The investigators want to explore which of these options can be used in Brussels out-of-hours primary care services to improve access for Dutch-speaking citizens. The objective of this study is to examine both barriers and facilitators to use these technological translation tools during language-discordant consultations with a French-speaking GP and a Dutch-speaking patient in Brussels out-of-hours primary care services. To achieve this objective, the investigators aim to engage Dutch-speaking patients, Dutch- and/or French-speaking GPs, as well as Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors. There will be about 40 participants in total. Participants will answer questions during an online group session (focus group). There will be 4 focus groups, with a maximum of 10 participants in each focus group. Each focus group will last 60-90 minutes.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Vrije Universiteit Brussel
Jette, Brussels Capital, Belgium
Start Date
December 10, 2024
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
December 27, 2024
40
ESTIMATED participants
Focus Group
OTHER
Lead Sponsor
Universitair Ziekenhuis Brussel
Collaborators
NCT05283265
NCT07369960
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07189104